David Loven
Impact in
Papers in
- Oncology 18
- Cancer Cells and Metastasis 3
-
- Angiogenesis and VEGF in Cancer 3
- Extracellular vesicles in disease 3
- Co-authors
- Yuval Shaked (7 shared papers)Francesco Bertolini (2 shared papers)Z. Harry Rappaport (5 shared papers)Dror Alishekevitz (4 shared papers)Svetlana Gingis‐Velitski (3 shared papers)Erez Hasnis (1 shared paper)Tali Voloshin (3 shared papers)Aarón Sulkes (3 shared papers)
- Journals
- Cancer (4 papers)Journal of neurosurgery (2 papers)Neurosurgery (2 papers)Child s Nervous System (1 paper)Oncotarget (1 paper)
- Partner nations
- IsraelItalySwitzerland
In The Last Decade
David Loven
39 papers receiving 890 citations
Peers
Comparison fields: 5 of 82
- Oncology 373
- Genetics 111
- Immunology 141
- Neurology 96
- Cancer Research 95
Countries citing papers authored by David Loven
This map shows the geographic impact of David Loven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Loven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Loven more than expected).
Fields of papers citing papers by David Loven
This network shows the impact of papers produced by David Loven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Loven. The network helps show where David Loven may publish in the future.
Co-authors
The 25 scholars most cited alongside David Loven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 102 | |
| 2 | 2016 | 97 | |
| 3 | 2004 | 81 | |
| 4 | 2012 | 58 | |
| 5 | 1994 | 53 | |
| 6 | 2008 | 49 | |
| 7 | 1994 | 37 | |
| 8 | 2006 | 32 | |
| 9 | 2013 | 31 | |
| 10 | 2006 | 27 | |
| 11 | Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects. | 1987 | 27 |
| 12 | 1994 | 25 | |
| 13 | 2004 | 25 | |
| 14 | 2017 | 21 | |
| 15 | 2001 | 19 | |
| 16 | 1991 | 19 | |
| 17 | 1991 | 17 | |
| 18 | 1991 | 17 | |
| 19 | 1992 | 17 | |
| 20 | 1991 | 17 |
About David Loven
David Loven is a scholar working on Oncology, Molecular Biology, Genetics, Pulmonary and Respiratory Medicine and Epidemiology, having authored 39 papers that have together received 938 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (5 papers), Glioma Diagnosis and Treatment (5 papers), Cancer Cells and Metastasis (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Brain Metastases and Treatment (3 papers), Extracellular vesicles in disease (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Oncology (373 citations), Genetics (111 citations), Immunology (141 citations), Neurology (96 citations) and Cancer Research (95 citations). David Loven has collaborated with scholars based in Israel, Italy and Switzerland. Frequent co-authors include Yuval Shaked, Francesco Bertolini, Z. Harry Rappaport, Dror Alishekevitz, Svetlana Gingis‐Velitski, Erez Hasnis, Tali Voloshin, Aarón Sulkes, H. Lurie and Eyal Fenig. Their work appears in journals such as Cancer, Journal of neurosurgery, Neurosurgery, Child s Nervous System and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.